US Merger & Acquisition SEC Filings — June 12, 2026

12-06-2026

FutureCorp Space Acquisition 1, a blank-check SPAC, filed an 8-K on June 12, 2026, reporting the closing of its initial public offering (IPO) and a simultaneous private placement on June 9, 2026. The company raised gross proceeds of $230,000,000 from the IPO of 23,000,000 units at $10.00 per unit (including full exercise of the underwriters' over-allotment option) and $6,000,000 from the sale of 6,000,000 private placement warrants at $1.00 each, bringing total trust account proceeds to $230,000,000. The filing includes an audited balance sheet as of June 8, 2026, and notes that the company has not yet commenced operations or selected a business combination target.

• · The company is incorporated in the Cayman Islands and has a fiscal year end of December 31.
• · Transaction costs of $14,498,434 were incurred, including $4M cash underwriting fee, $9.8M deferred underwriting fee, and $698,434 in other offering costs.
• · The company has an accumulated deficit of $8,617,340 and a total shareholders' deficit of $8,616,765.
• · Auditor is WithumSmith+Brown, PC, engaged since 2026.
• · The Business Combination must involve a target with a fair market value of at least 80% of the net trust account balance at signing.
• · Trust proceeds are initially invested in U.S. government treasury obligations or money market funds meeting Rule 2a-7 conditions; the company may later convert to cash in a demand deposit account to mitigate investment company risk.

12-06-2026

JAB Acquisition Sponsor I, LLC filed a Schedule 13D disclosing beneficial ownership of 10,442,143 shares (36.4% of total outstanding) in JAB Acquisition Corp I as of June 11, 2026. The sponsor acquired 9,857,143 Class B shares for $25,000 ($0.002/share) on March 19, 2026, and purchased 260,000 private units for $2.6M concurrent with the company's June 11 IPO, which raised $172.5M from 17.25M units at $10/unit. The filing indicates the sponsor intends to pursue a business combination but currently has no specific plans for extraordinary transactions beyond those described.

• · The sponsor's Class B shares ($0.002/sh) will convert into Class A shares on a 1-for-1 basis upon consummation of a business combination, subject to customary adjustments.
• · Underwriters' over-allotment option was exercised in full for an additional 2,250,000 units.
• · An additional 1,000,000 Class A ordinary shares were issued to D. Boral Capital LLC as representative of the underwriters.
• · The sponsor has sole voting and dispositive power over all 10,442,143 shares.
• · The filing states the sponsor has no current plans for extraordinary transactions but reserves the right to formulate other purposes in the future.
• · No transactions in the ordinary shares were effected by the Reporting Person in the 60 days prior to the filing date beyond those reported.

12-06-2026

Future Vision II Acquisition Corp. has issued a $191,475 unsecured promissory note to HWei Super Speed Co. Ltd. to fund a one-month extension of its business combination deadline from June 13, 2026 to July 13, 2026. The note bears zero interest, is convertible into units at $10.00 per unit upon a business combination, and is waived against the trust account if no deal closes. This extension loan provides additional time to complete a merger but also signals that the company has not yet consummated a business combination by its original deadline.

• · The note is unsecured and bears no interest.
• · Conversion price is $10.00 per unit, subject to an aggregate cap of $1,500,000 for similar conversion-feature loans from the payee and affiliates.
• · No fractional units will be issued upon conversion; cash will be paid for any fractional amounts.
• · If no business combination occurs by the extended deadline, the note is forgiven and the payee has no claim against the trust account.
• · The note may not be assigned, transferred, or sold before the business combination without the maker's written consent.
• · Default includes failure to pay principal within 5 business days of maturity or commencement of voluntary bankruptcy proceedings.

12-06-2026

Rocket Pharmaceuticals closed the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) for $180 million in gross proceeds, providing a non-dilutive capital infusion. Before the sale, the company had $144.4 million in cash and investments (as of March 31, 2026), and pro forma liquidity increased to approximately $322.6 million, which is expected to fund operations into Q2 2028. The PRV was granted by the FDA in March 2026 in connection with the approval of KRESLADI™, Rocket's gene therapy for severe LAD-I.

• · The PRV was granted by the FDA in March 2026 in connection with the approval of KRESLADI™, Rocket's gene therapy for severe leukocyte adhesion deficiency-I (LAD-I).
• · Rocket expects the pro forma cash of ~$322.6 million to fund operations into the second quarter of 2028.
• · Rocket's cardiovascular pipeline includes three clinical stage programs targeting inherited cardiomyopathy subtypes: hypertrophic, arrhythmogenic, and dilated cardiomyopathies, representing more than 100,000 patients in the U.S. and EU.
• · The company describes itself as a fully integrated, commercial-stage biotechnology company.

12-06-2026

Centurion Acquisition Corp. entered into Non-Redemption Agreements with certain shareholders on June 11, 2026, securing commitments not to redeem an aggregate of 4,675,000 Class A ordinary shares and to vote in favor of extending the business combination deadline from June 12, 2026 to June 12, 2027. In exchange, the Sponsor will transfer 1,558,333 Class A ordinary shares to participating investors upon closing of the initial business combination. The agreements aim to increase the likelihood of shareholder approval for the extension and preserve trust account funds, though the outcome remains subject to shareholder vote and the company's ability to complete a business combination within the extended timeframe.

• · The Non-Redemption Agreements were entered into on June 11, 2026, and filed on June 12, 2026.
• · The extension proposal seeks to move the business combination deadline from June 12, 2026 to June 12, 2027.
• · The Sponsor's Class B ordinary shares were converted into Class A ordinary shares on June 8, 2026.
• · The definitive proxy statement was filed on May 21, 2026, and mailed to shareholders of record as of May 6, 2026 on or about May 22, 2026.
• · Each Non-Redemption Agreement terminates upon the earliest of: failure to approve extension, fulfillment of obligations, company liquidation, mutual written agreement, or investor exercising redemption rights or failing to vote in favor.
• · The company and sponsor may enter into additional similar non-redemption agreements in connection with the EGM.
• · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.

12-06-2026

Inflection Point Acquisition Corp. VI (IPFX) has entered into a definitive Business Combination Agreement to merge with Quantum Space, LLC, a space infrastructure company, in a deal valued at approximately $60 million in Series B investment plus PIPE financing. The transaction involves a complex structure including a domestication of the SPAC from Cayman Islands to Delaware, a merger of a subsidiary with the SPAC, and contributions of equity by Quantum Space's sellers and Series B investors. While the agreement provides a clear path to public listing for Quantum Space, the filing does not disclose specific financial performance metrics or growth rates, limiting the ability to assess the target's operational health.

• · The Business Combination Agreement was executed on June 8, 2026.
• · The transaction includes a Domestication of the Purchaser from Cayman Islands to Delaware prior to closing.
• · Immediately prior to closing, the Company will effectuate a Recapitalization converting all outstanding equity securities (except Series B Preferred Units and Series B Warrants) into Company Common Units.
• · At closing, Merger Sub will merge with and into Purchaser, with Purchaser surviving as a wholly owned subsidiary of Pubco.
• · Each share of Domesticated Purchaser Class A Common Stock will convert into one share of Pubco Class A-1 Common Stock.
• · Each Domesticated Purchaser Warrant will convert into a warrant to acquire one share of Pubco Class A-1 Common Stock.
• · Sellers (Direct Pubco Sellers and Up-C Sellers) will contribute Company Common Units to Pubco in exchange for Pubco Class A-1 or Class A-2 Common Stock.
• · Series B Investors will contribute Series B Preferred Units in exchange for Pubco Convertible Preferred Stock, with an option to also contribute Series B Warrants for Preferred Investor Warrants.
• · Up-C Sellers will purchase shares of Pubco Class B-1 or Class B-2 Common Stock in respect of retained Company Common Units.
• · The Sponsor has executed a Sponsor Support Agreement to vote in favor of the transaction.
• · Required Members have executed a Member Support Agreement to approve the transaction.
• · PIPE Subscription Agreements have been executed with investors.
• · The filing does not disclose the total enterprise value, revenue, EBITDA, or any historical financial data of Quantum Space.

12-06-2026

On June 12, 2026, Translational Development Acquisition Corp. issued 4,657,499 Class A ordinary shares to sponsor TDAC Partners LLC upon conversion of an equal number of Class B ordinary shares. The conversion did not generate any cash proceeds and did not affect the trust account balance or the per-share redemption value of approximately $10.69 per public share. Following the conversion, there are 21,907,499 Class A ordinary shares and one Class B ordinary share outstanding.

• · The Class A ordinary shares issued are subject to the same restrictions as the Class B ordinary shares prior to conversion, including transfer restrictions, waiver of redemption rights, and obligation to vote in favor of an initial business combination.
• · The conversion was exempt from registration under Section 3(a)(9) of the Securities Act of 1933.
• · No underwriter was involved and no commission or remuneration was paid for soliciting the conversion.

12-06-2026

Athena Technology Acquisition Corp. II (ATEK) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation on June 11, 2026, extending the deadline to complete an initial business combination from the original 24 months to 63 months from the closing of its offering. The amendment was approved by holders of at least 65% of outstanding shares and extends the trust account release timeline, allowing the company more time to pursue a merger or acquisition. No financial results or performance metrics were disclosed in this filing.

• · The original Certificate of Incorporation was filed on May 20, 2021, and the Amended and Restated Certificate was filed on December 14, 2021.
• · Previous amendments were made on June 13, 2023, June 20, 2023, March 12, 2024, December 10, 2024, and September 10, 2025.
• · This is the sixth amendment to the Amended and Restated Certificate of Incorporation.
• · The amendment was adopted in accordance with Article IX of the Amended and Restated Certificate of Incorporation and Section 242 of the DGCL.
• · The trust account funds will not be released until the earliest of: completion of initial business combination, the 63-month deadline, or redemption in connection with a vote to amend certain provisions.

12-06-2026

Irenic Acquisition Corp. announced that holders of its units from its IPO may elect to separately trade the Class A ordinary shares and warrants starting June 18, 2026. The units consist of one Class A ordinary share and one-third of one warrant, with each whole warrant exercisable for one Class A ordinary share at $11.50 per share. No fractional warrants will be issued, and the separate securities will trade on Nasdaq under symbols IACQ and IACQW.

• · The separate trading election becomes effective on June 18, 2026.
• · Holders must have their brokers contact Continental Stock Transfer & Trust Company to separate units.
• · Only whole warrants will trade; no fractional warrants will be issued.
• · The warrants have an exercise price of $11.50 per share.

12-06-2026

LeafBuyer Technologies (LBUY) completed its reverse merger with RagingBull.com, LLC, resulting in a change of control where RagingBull equity holders now own approximately 95% of the combined company. The company changed its name to DATZ World Holdings Corp, effected a 1-for-156 reverse stock split, and issued 15,000,000 new shares to RagingBull holders. Additionally, the company sold its subsidiary LB Media Group for $750,000 cash and restructured over $1 million in debt via convertible notes, though the overall transaction reflects a transformative but dilutive event for legacy shareholders.

• · The Merger Agreement was dated November 10, 2025, but the merger closed on June 8, 2026.
• · Outstanding promissory notes to Jeff Bishop and MFA were partially repaid ($750,000 cash) and the balances exchanged for new convertible notes with 3% annual interest, 5-year maturity, and conversion price of $0.05 per share.
• · The Series A Convertible Preferred Stock (324,327 shares) sold to Jeff Bishop entitles him to vote on an as-converted basis equal to 55% of the Company’s outstanding voting stock, even though his common stock ownership is 63.9%.
• · Anthony Bell, the new CEO, previously served as CFO of RagingBull.com since January 2025 and studied accounting at UNC Asheville without completing a degree.
• · The company is classified as an emerging growth company and has elected not to use the extended transition period for complying with new accounting standards.
• · The financial statements of RagingBull.com (audited and unaudited) and pro forma combined financials are to be filed by amendment within 71 calendar days.
• · The reverse split ratio of 1-for-156 was applied to all common stock outstanding prior to the merger.

12-06-2026

M3-Brigade Acquisition V Corp. filed an 8-K on June 12, 2026, reporting the entry into a material definitive agreement (Item 1.01), termination of a material definitive agreement (Item 1.02), and other events (Item 8.01). The filing size is 780 KB, but no specific deal terms, parties, valuation, or financial metrics are disclosed in the provided summary. The filing is purely procedural with no quantitative data available for analysis.

12-06-2026

Ashford Hospitality Trust completed the sale of the 260-room Sheraton San Diego Mission Valley on June 9, 2026, for approximately $45.0 million in net cash proceeds, using $35.9 million of that to repay the mortgage lender. The pro forma financials show the disposition reduces total assets by about $33.9 million and improves the company's net loss attributable to common stockholders by $7.3 million for FY2025 and by $0.6 million for Q1 2026. However, the company continues to report significant net losses—$206.3 million pro forma for FY2025 and $70.5 million for Q1 2026—and carries a large accumulated deficit of $3.09 billion.

• · The mortgage loan repaid was secured by 15 hotels, including Sheraton San Diego.
• · Pro forma net loss attributable to common stockholders improved from $215.0M to $206.3M for FY2025 and from $71.1M to $70.5M for Q1 2026.
• · The company's pro forma accumulated deficit remains very high at $3.09B as of March 31, 2026.
• · Pro forma total hotel revenue declined by approximately $15.3M (1.4%) for FY2025 and $3.5M (1.3%) for Q1 2026 due to the removal of Sheraton San Diego's operations.
• · The pro forma gain on disposition is preliminary and subject to change.

12-06-2026

Snow Rothschild Acquisition Corp. announced the pricing of its $200 million initial public offering of 20,000,000 units at $10.00 per unit, with each unit consisting of one Class A ordinary share and one-half of one redeemable warrant. The units are expected to begin trading on Nasdaq under the symbol "ISNRU" on June 9, 2026, and the closing is anticipated on June 10, 2026. The company is a blank check company focused on industrial assets, led by CEO Ian Snow, Chairman Nathaniel Rothschild, and CFO William Chai.

• · The company has granted the underwriter a 45-day option to purchase up to an additional 3,000,000 units at the IPO price less underwriting discount to cover over-allotments.
• · The registration statement was declared effective by the SEC on June 8, 2026.
• · The company is a blank check company formed for the purpose of effecting a merger or similar business combination, with a focus on industrial assets.

12-06-2026

Pantages Capital Acquisition Corp (PGACU) filed an 8-K on June 12, 2026, announcing that at the June 3, 2026 extraordinary annual meeting shareholders approved an extension of the deadline to consummate a business combination from June 6, 2026 to June 6, 2027, on a month-to-month basis. In connection with the vote, approximately 5.89 million shares were tendered for redemption, resulting in about $62.4 million (approx. $10.60 per share) being removed from the trust account, leaving roughly $29.0 million in trust and reducing the outstanding Class A shares to 2,980,156. This represents significant shareholder redemptions (approximately 66% of the previously outstanding public shares were redeemed), reflecting substantial investor unease about the extension.

• · Extension is month-to-month for up to 12 months after the original termination date, with a maximum deposit of $60,000 per month.
• · After redemptions, total outstanding shares are 2,980,156 Class A and 2,156,250 Class B shares.
• · The filing does not mention any potential target or business combination progress.
• · 19-month extension period (from June 2026 to June 2027) suggests significant time needed to consummate a deal.
• · The trust account was reduced from approximately $91.4 million to $29.0 million — a drop of over 68% from implicit pre-redemption total.
• · Pre-redemption implicit trust per share was $10.60; post-redemption trust per Class A share is approximately $9.73, indicating a decline in per-share trust value.

12-06-2026

Titan Acquisition Corp. entered into a First Amendment to its Business Combination Agreement with OpenPayd Global Holdings Limited and OpenPayd Holdings Limited on June 11, 2026, to correct a scrivener's error related to Transferred Warrants. The amendment deletes a parenthetical in Section 8.26 of the original agreement, but no financial terms or changes to deal consideration were disclosed.

• · The original Business Combination Agreement was entered into on June 1, 2026.
• · The amendment corrects a scrivener's error in Section 8.26 of the original agreement by deleting the parenthetical '(other than any Purchaser Private Warrants representing the Transferred Warrants)'.
• · The amendment is effective as of June 11, 2026.
• · No other terms of the Business Combination Agreement were modified.

12-06-2026

AmperCap Acquisition Co. reported the partial exercise of its over-allotment option in connection with its June 4, 2026 IPO, resulting in the sale of an additional 1,837,500 Option Units at $10.00 per unit for gross proceeds of $18,375,000. Concurrently, the sponsor and underwriter purchased 55,125 additional Private Placement Units at $10.00 per unit for $551,250. Following these transactions, approximately $144,808,750 of total proceeds are held in trust. However, the remaining 37,500 Option Units were not exercised, and 12,500 founder shares were forfeited by the sponsor as a result.

• · The IPO closed on June 4, 2026, with 12,500,000 Units sold at $10.00 per unit.
• · The over-allotment option was partially exercised on June 10, 2026, for 1,837,500 Option Units; the remaining 37,500 were not exercised.
• · 12,500 founder shares were forfeited by the sponsor on June 10, 2026, due to the underwriters not exercising the remainder of the over-allotment option.
• · No underwriting discounts or commissions were paid on the Private Placement Units.
• · The Private Placement Units are identical to IPO Units except as disclosed in the registration statement.

12-06-2026

Real Asset Acquisition Corp. (RAAQ) filed an 8-K on June 12, 2026, announcing that IQM Finland Oy issued a press release regarding the appointment of Barbara Venneman to IQM's Board of Directors. This update relates to the previously announced business combination between RAAQ and IQM, which is expected to result in IQM becoming a publicly traded company. The filing does not provide any financial performance data or period-over-period comparisons.

• · The Registration Statement for the business combination was declared effective by the SEC on June 5, 2026.
• · RAAQ mailed the definitive proxy statement/prospectus to shareholders as of June 3, 2026, the record date for voting at the Extraordinary General Meeting.
• · The business combination agreement was originally entered into on February 22, 2026.
• · RAAQ's securities trade on Nasdaq under symbols RAAQU (Units), RAAQ (Class A ordinary shares), and RAAQW (Redeemable warrants).

12-06-2026

Inception Growth Acquisition Ltd deposited $12,203.33 into its trust account on June 11, 2026, to extend the deadline for completing a business combination by one month, from June 13, 2026, to July 13, 2026. The extension indicates the Company has not yet consummated a merger, and there is no associated financial performance data in this filing.

• · The Company's securities are traded on OTC Markets Group, Inc. under symbols: IGTAU (Units), IGTA (Common Stock), IGTAW (Warrants), IGTAR (Rights).
• · The extension deposit was made on June 11, 2026, and the press release was issued on June 12, 2026.
• · Warrants are exercisable at $11.50 per share.
• · The Company is a blank check (SPAC) focused on effecting a merger or similar business combination.